EUR 0.85
(2.41%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | -1.61 Million EUR | 99.81% |
2022 | -856.6 Thousand EUR | 73.6% |
2021 | -3.24 Million EUR | -3.35% |
2020 | -3.13 Million EUR | 1.29% |
2019 | -3.17 Million EUR | -12.61% |
2018 | -2.82 Million EUR | -84775.2% |
2017 | -3326.86 EUR | 9.87% |
2016 | -3691.38 EUR | -90.92% |
2015 | -1933.51 EUR | 99.92% |
2014 | -2.36 Million EUR | -77.73% |
2013 | -1.32 Million EUR | -66.15% |
2012 | -800.18 Thousand EUR | -155.7% |
2011 | -312.93 Thousand EUR | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q2 | -1.11 Million EUR | 0.0% |
2023 Q2 | -1.15 Million EUR | 0.0% |
2023 FY | -1.61 Million EUR | -88.3% |
2023 Q4 | -454 Thousand EUR | 0.0% |
2022 Q4 | -448.14 Thousand EUR | 0.0% |
2022 FY | -856.6 Thousand EUR | 73.6% |
2022 Q2 | -408.46 Thousand EUR | 0.0% |
2021 FY | -3.24 Million EUR | -3.35% |
2021 Q4 | -1.44 Million EUR | 0.0% |
2021 Q2 | -1.8 Million EUR | 0.0% |
2020 Q2 | -1.53 Million EUR | 0.0% |
2020 FY | -3.13 Million EUR | 1.29% |
2020 Q4 | -1.6 Million EUR | 0.0% |
2019 Q4 | -1732.01 EUR | 0.0% |
2019 Q2 | -1445.55 EUR | 0.0% |
2019 FY | -3.17 Million EUR | -12.61% |
2018 Q2 | -604 Thousand EUR | 0.0% |
2018 Q4 | -4.95 Million EUR | 0.0% |
2018 FY | -2.82 Million EUR | -84775.2% |
2017 Q4 | -1495.60 EUR | 0.0% |
2017 FY | -3326.86 EUR | 9.87% |
2017 Q2 | -1812.83 EUR | 0.0% |
2016 FY | -3691.38 EUR | -90.92% |
2016 Q2 | -1457.47 EUR | 0.0% |
2016 Q4 | -2233.92 EUR | 0.0% |
2015 FY | -1933.51 EUR | 99.92% |
2015 Q2 | -1441.86 EUR | 0.0% |
2015 Q4 | -491.65 EUR | 0.0% |
2014 Q1 | -601.27 Thousand EUR | 0.0% |
2014 Q2 | -1146.20 EUR | 99.81% |
2014 Q4 | -1252.04 EUR | 99.79% |
2014 FY | -2.36 Million EUR | -77.73% |
2014 Q3 | -601.27 Thousand EUR | -52358.07% |
2013 Q3 | -330.39 Thousand EUR | 0.0% |
2013 Q1 | -330.39 Thousand EUR | 0.0% |
2013 Q4 | -601.27 Thousand EUR | -81.99% |
2013 FY | -1.32 Million EUR | -66.15% |
2013 Q2 | -330.39 Thousand EUR | 0.0% |
2012 FY | -800.18 Thousand EUR | -155.7% |
2012 Q2 | -172.15 Thousand EUR | 0.0% |
2012 Q4 | -330.39 Thousand EUR | -91.92% |
2012 Q1 | -172.15 Thousand EUR | 0.0% |
2012 Q3 | -172.15 Thousand EUR | 0.0% |
2011 Q2 | -87.29 Thousand EUR | 0.0% |
2011 FY | -312.93 Thousand EUR | 0.0% |
2011 Q3 | -87.29 Thousand EUR | 0.0% |
2011 Q1 | -87.29 Thousand EUR | 0.0% |
2011 Q4 | -172.15 Thousand EUR | -97.21% |
2010 Q4 | -87.29 Thousand EUR | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
Affluent Medical SA | -13.06 Million EUR | 87.658% |
Carmat SA | -52.51 Million EUR | 96.929% |
Diagnostic Medical Systems S.A. | -2.26 Million EUR | 28.801% |
Euromedis Groupe | -5.55 Million EUR | 70.981% |
Eurobio Scientific Société anonyme | 10.14 Million EUR | 115.902% |
Ikonisys S.A. | -2.19 Million EUR | 26.488% |
Implanet S.A. | -6.15 Million EUR | 73.816% |
Median Technologies SA | -23 Million EUR | 92.99% |
SpineGuard SA | -3.97 Million EUR | 59.441% |
Theraclion SA | -3.15 Million EUR | 48.869% |
Euroapi S.A. | -234.3 Million EUR | 99.312% |
Guerbet SA | 38.67 Million EUR | 104.17% |
Ion Beam Applications SA | 5.09 Million EUR | 131.671% |
Koninklijke Philips N.V. | -115 Million EUR | 98.598% |
Sequana Medical NV | -29.49 Million EUR | 94.532% |